Jinling Hospital, China
Clinical trials sponsored by Jinling Hospital, China, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for kidney cancer: Real-World study tests vorolanib as Second-Line therapy Results expected Sep 2026 (estimated)
- Wrist vs groin: which artery route is best for stroke clot removal? Results expected Sep 2026 (estimated)
- New rad combo targets kidney cancer after immunotherapy fails Results expected Sep 2026 (estimated)
- Could a common bile acid pill shield kidneys during cancer surgery? Results expected Oct 2026 (estimated)
- New hope for liver cancer patients: 4-drug combo targets untreatable tumors Results expected Nov 2026 (estimated)
-
Could a food additive help fight stomach cancer? new trial explores
Disease control Not yet recruitingThis study tests whether adding sodium propionate, a common food preservative, to standard immunotherapy and chemotherapy can improve tumor shrinkage in people with advanced stomach cancer. About 20 adults with inoperable gastric cancer will be randomly assigned to receive either…
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Immunotherapy plus chemo shows promise for pancreatic cancer before surgery
Disease control Not yet recruitingThis phase 2 trial is testing whether adding the immunotherapy drug adebrelimab to standard chemotherapy can help shrink pancreatic tumors before surgery. About 30 people with resectable pancreatic cancer will receive the combination, and researchers will measure how many tumors …
Phase 2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for liver cancer patients: 4-drug combo targets untreatable tumors
Disease control Not yet recruitingThis study tests a powerful combination of treatments for people with liver cancer that cannot be surgically removed. It combines two local therapies (TACE and SBRT) with an immunotherapy drug and a targeted pill (donafenib) as the first treatment. The goal is to shrink tumors an…
Phase 2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New feeding strategy may cut pneumonia risk in severe stroke patients
Prevention Not yet recruitingThis study compares two ways of feeding patients with severe ischemic stroke who have trouble swallowing. The goal is to see if feeding through a tube placed past the stomach (post-pyloric) reduces the chance of developing pneumonia compared to standard stomach feeding. About 174…
Phase 4 • Sponsor: Jinling Hospital, China • Aim: Prevention
Last updated Jun 27, 2026 13:02 UTC